Blog

Deciphera stock surges on gastrointestinal cancer drug success

steve-hoerter900xx907-1360-107-0

After sixteen years of work, Waltham drugmaker Deciphera Pharmaceuticals Inc. is set to ask the FDA for permission to bring its first product to market next year.

Read More